Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
NervGen Pharma Corp. (NGEN) had Return on Equity of 23.06% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$7.80M |
|
-- |
|
-- |
|
$8.57M |
|
$-8.57M |
|
$16.37M |
|
$7.80M |
|
$7.80M |
|
$7.80M |
|
$7.80M |
|
$7.80M |
|
$7.80M |
|
$-8.57M |
|
$-8.56M |
|
92.44M |
|
105.10M |
|
$0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$64.87M |
|
-- |
|
$0.28M |
|
$65.14M |
|
$31.31M |
|
-- |
|
-- |
|
$31.31M |
|
$33.83M |
|
$33.56M |
|
$33.83M |
|
106.41M |
|
| Cash Flow Statement Financials | |
$-10.06M |
|
$0.01M |
|
$58.45M |
|
$15.94M |
|
$62.69M |
|
$46.75M |
|
$2.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.07 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
23.06% |
23.25% |
|
11.98% |
|
23.06% |
|
$0.32 |
|
$-0.10 |
|
$-0.10 |
|